Given these constraints and nuances like PIK3CA mutation-site biology and class-specific toxicities (e.g., hyperglycemia with PI3Kα inhibitors), future trials should enrich for HPV-independent histotypes. This evidence concerns the gene PIK3CA and Hyperglycemia.